Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Development and evaluation of a novel VHH-based immunocapture assay for high sensitivity detection of Shiga toxin type 2 (Stx2) in stool samples.

Melli LJ, Zylberman V, Hiriart Y, Lauche CE, Baschkier A, Pardo R, Miliwebsky E, Chinen I, Rivas M, Goldbaum FA, Ugalde JE, Comerci DJ, Ciocchini AE.

J Clin Microbiol. 2019 Dec 11. pii: JCM.01566-19. doi: 10.1128/JCM.01566-19. [Epub ahead of print]

PMID:
31826960
2.

Brucella abortus Depends on l-Serine Biosynthesis for Intracellular Proliferation.

Révora V, Marchesini MI, Comerci DJ.

Infect Immun. 2020 Jan 22;88(2). pii: e00840-19. doi: 10.1128/IAI.00840-19. Print 2020 Jan 22.

PMID:
31740531
3.

Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System.

Pasquevich KA, Carabajal MV, Guaimas FF, Bruno L, Roset MS, Coria LM, Rey Serrantes DA, Comerci DJ, Cassataro J.

Front Immunol. 2019 Jun 26;10:1436. doi: 10.3389/fimmu.2019.01436. eCollection 2019.

4.

Improving bioreactor production of a recombinant glycoprotein in Escherichia coli: Effect of specific growth rate on protein glycosylation and specific productivity.

Caillava AJ, Ortiz GE, Melli LJ, Ugalde JE, Ciocchini AE, Comerci DJ.

Biotechnol Bioeng. 2019 Jun;116(6):1427-1438. doi: 10.1002/bit.26953. Epub 2019 Feb 28.

PMID:
30739323
5.

Glyco-iELISA: a highly sensitive and unambiguous serological method to diagnose STEC-HUS caused by serotype O157.

Wijnsma KL, Veissi ST, van Bommel SAM, Heuver R, Volokhina EB, Comerci DJ, Ugalde JE, van de Kar NCAJ, van den Heuvel LPWJ.

Pediatr Nephrol. 2019 Apr;34(4):631-639. doi: 10.1007/s00467-018-4118-9. Epub 2018 Oct 26.

6.

Cyclic β-glucans at the bacteria-host cells interphase: One sugar ring to rule them all.

Guidolin LS, Arce-Gorvel V, Ciocchini AE, Comerci DJ, Gorvel JP.

Cell Microbiol. 2018 Jun;20(6):e12850. doi: 10.1111/cmi.12850. Epub 2018 May 9. Review.

PMID:
29624823
7.

Brucella abortus Promotes a Fibrotic Phenotype in Hepatic Stellate Cells, with Concomitant Activation of the Autophagy Pathway.

Arriola Benitez PC, Pesce Viglietti AI, Herrmann CK, Dennis VA, Comerci DJ, Giambartolomei GH, Delpino MV.

Infect Immun. 2017 Dec 19;86(1). pii: e00522-17. doi: 10.1128/IAI.00522-17. Print 2018 Jan.

8.

A recombinant O-polysaccharide-protein conjugate approach to develop highly specific monoclonal antibodies to Shiga toxin-producing Escherichia coli O157 and O145 serogroups.

Castillo DS, Rey Serantes DA, Melli LJ, Ciocchini AE, Ugalde JE, Comerci DJ, Cassola A.

PLoS One. 2017 Oct 5;12(10):e0182452. doi: 10.1371/journal.pone.0182452. eCollection 2017.

9.

Btp Proteins from Brucella abortus Modulate the Lung Innate Immune Response to Infection by the Respiratory Route.

Hielpos MS, Ferrero MC, Fernández AG, Falivene J, Vanzulli S, Comerci DJ, Baldi PC.

Front Immunol. 2017 Aug 24;8:1011. doi: 10.3389/fimmu.2017.01011. eCollection 2017.

10.

Development of improved enzyme-based and lateral flow immunoassays for rapid and accurate serodiagnosis of canine brucellosis.

Cortina ME, Novak A, Melli LJ, Elena S, Corbera N, Romero JE, Nicola AM, Ugalde JE, Comerci DJ, Ciocchini AE.

Vet Microbiol. 2017 Sep;208:174-180. doi: 10.1016/j.vetmic.2017.08.005. Epub 2017 Aug 7.

PMID:
28888634
11.

A T4SS Effector Targets Host Cell Alpha-Enolase Contributing to Brucella abortus Intracellular Lifestyle.

Marchesini MI, Morrone Seijo SM, Guaimas FF, Comerci DJ.

Front Cell Infect Microbiol. 2016 Nov 16;6:153. eCollection 2016.

12.

Brucella abortus Strain 2308 Wisconsin Genome: Importance of the Definition of Reference Strains.

Suárez-Esquivel M, Ruiz-Villalobos N, Castillo-Zeledón A, Jiménez-Rojas C, Roop Ii RM, Comerci DJ, Barquero-Calvo E, Chacón-Díaz C, Caswell CC, Baker KS, Chaves-Olarte E, Thomson NR, Moreno E, Letesson JJ, De Bolle X, Guzmán-Verri C.

Front Microbiol. 2016 Sep 29;7:1557. eCollection 2016.

13.

A Bacterial Glycoengineered Antigen for Improved Serodiagnosis of Porcine Brucellosis.

Cortina ME, Balzano RE, Rey Serantes DA, Caillava AJ, Elena S, Ferreira AC, Nicola AM, Ugalde JE, Comerci DJ, Ciocchini AE.

J Clin Microbiol. 2016 Jun;54(6):1448-1455. doi: 10.1128/JCM.00151-16. Epub 2016 Mar 16.

14.

Electrochemical magnetic microbeads-based biosensor for point-of-care serodiagnosis of infectious diseases.

Cortina ME, Melli LJ, Roberti M, Mass M, Longinotti G, Tropea S, Lloret P, Serantes DAR, Salomón F, Lloret M, Caillava AJ, Restuccia S, Altcheh J, Buscaglia CA, Malatto L, Ugalde JE, Fraigi L, Moina C, Ybarra G, Ciocchini AE, Comerci DJ.

Biosens Bioelectron. 2016 Jun 15;80:24-33. doi: 10.1016/j.bios.2016.01.021. Epub 2016 Jan 14.

PMID:
26802749
15.

The Effector Protein BPE005 from Brucella abortus Induces Collagen Deposition and Matrix Metalloproteinase 9 Downmodulation via Transforming Growth Factor β1 in Hepatic Stellate Cells.

Arriola Benitez PC, Rey Serantes D, Herrmann CK, Pesce Viglietti AI, Vanzulli S, Giambartolomei GH, Comerci DJ, Delpino MV.

Infect Immun. 2015 Dec 14;84(2):598-606. doi: 10.1128/IAI.01227-15. Print 2016 Feb.

16.

Interaction network and localization of Brucella abortus membrane proteins involved in the synthesis, transport, and succinylation of cyclic β-1,2-glucans.

Guidolin LS, Morrone Seijo SM, Guaimas FF, Comerci DJ, Ciocchini AE.

J Bacteriol. 2015 May;197(9):1640-8. doi: 10.1128/JB.00068-15. Epub 2015 Mar 2.

17.

Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome.

Melli LJ, Ciocchini AE, Caillava AJ, Vozza N, Chinen I, Rivas M, Feldman MF, Ugalde JE, Comerci DJ.

J Clin Microbiol. 2015 Feb;53(2):528-38. doi: 10.1128/JCM.02262-14. Epub 2014 Dec 3.

18.

A bacterial engineered glycoprotein as a novel antigen for diagnosis of bovine brucellosis.

Ciocchini AE, Serantes DA, Melli LJ, Guidolin LS, Iwashkiw JA, Elena S, Franco C, Nicola AM, Feldman MF, Comerci DJ, Ugalde JE.

Vet Microbiol. 2014 Aug 27;172(3-4):455-65. doi: 10.1016/j.vetmic.2014.04.014. Epub 2014 Apr 30.

PMID:
24984948
19.

Brucella alters the immune response in a prpA-dependent manner.

Spera JM, Comerci DJ, Ugalde JE.

Microb Pathog. 2014 Feb-Mar;67-68:8-13. doi: 10.1016/j.micpath.2014.01.003. Epub 2014 Feb 4.

20.

Brucella abortus induces collagen deposition and MMP-9 down-modulation in hepatic stellate cells via TGF-β1 production.

Arriola Benitez PC, Scian R, Comerci DJ, Serantes DR, Vanzulli S, Fossati CA, Giambartolomei GH, Delpino MV.

Am J Pathol. 2013 Dec;183(6):1918-1927. doi: 10.1016/j.ajpath.2013.08.006. Epub 2013 Oct 7.

21.

BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions.

Salcedo SP, Marchesini MI, Degos C, Terwagne M, Von Bargen K, Lepidi H, Herrmann CK, Santos Lacerda TL, Imbert PR, Pierre P, Alexopoulou L, Letesson JJ, Comerci DJ, Gorvel JP.

Front Cell Infect Microbiol. 2013 Jul 8;3:28. doi: 10.3389/fcimb.2013.00028. eCollection 2013.

22.

A Brucella virulence factor targets macrophages to trigger B-cell proliferation.

Spera JM, Herrmann CK, Roset MS, Comerci DJ, Ugalde JE.

J Biol Chem. 2013 Jul 12;288(28):20208-16. doi: 10.1074/jbc.M113.453282. Epub 2013 May 29.

23.

Development and validation of a novel diagnostic test for human brucellosis using a glyco-engineered antigen coupled to magnetic beads.

Ciocchini AE, Rey Serantes DA, Melli LJ, Iwashkiw JA, Deodato B, Wallach J, Feldman MF, Ugalde JE, Comerci DJ.

PLoS Negl Trop Dis. 2013;7(2):e2048. doi: 10.1371/journal.pntd.0002048. Epub 2013 Feb 14.

24.

Identification and characterization of a high-affinity choline uptake system of Brucella abortus.

Herrmann CK, Bukata L, Melli L, Marchesini MI, Caramelo JJ, Comerci DJ.

J Bacteriol. 2013 Feb;195(3):493-501. doi: 10.1128/JB.01929-12. Epub 2012 Nov 16.

25.

A MarR-Type regulator directly activates transcription from the Brucella abortus virB promoter by sharing a redundant role with HutC.

Sieira R, Arocena GM, Zorreguieta A, Comerci DJ, Ugalde RA.

J Bacteriol. 2012 Dec;194(23):6431-40. doi: 10.1128/JB.01007-12. Epub 2012 Sep 21.

26.

Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis.

Iwashkiw JA, Fentabil MA, Faridmoayer A, Mills DC, Peppler M, Czibener C, Ciocchini AE, Comerci DJ, Ugalde JE, Feldman MF.

Microb Cell Fact. 2012 Jan 25;11:13. doi: 10.1186/1475-2859-11-13.

27.

Brucella abortus choloylglycine hydrolase affects cell envelope composition and host cell internalization.

Marchesini MI, Connolly J, Delpino MV, Baldi PC, Mujer CV, DelVecchio VG, Comerci DJ.

PLoS One. 2011;6(12):e28480. doi: 10.1371/journal.pone.0028480. Epub 2011 Dec 8.

28.

In search of Brucella abortus type IV secretion substrates: screening and identification of four proteins translocated into host cells through VirB system.

Marchesini MI, Herrmann CK, Salcedo SP, Gorvel JP, Comerci DJ.

Cell Microbiol. 2011 Aug;13(8):1261-74. doi: 10.1111/j.1462-5822.2011.01618.x. Epub 2011 Jun 24.

29.

Genome of Ochrobactrum anthropi ATCC 49188 T, a versatile opportunistic pathogen and symbiont of several eukaryotic hosts.

Chain PS, Lang DM, Comerci DJ, Malfatti SA, Vergez LM, Shin M, Ugalde RA, Garcia E, Tolmasky ME.

J Bacteriol. 2011 Aug;193(16):4274-5. doi: 10.1128/JB.05335-11. Epub 2011 Jun 17.

30.

Identification of the quorum-sensing target DNA sequence and N-Acyl homoserine lactone responsiveness of the Brucella abortus virB promoter.

Arocena GM, Sieira R, Comerci DJ, Ugalde RA.

J Bacteriol. 2010 Jul;192(13):3434-40. doi: 10.1128/JB.00232-10. Epub 2010 Apr 16.

31.

An atypical riboflavin pathway is essential for Brucella abortus virulence.

Bonomi HR, Marchesini MI, Klinke S, Ugalde JE, Zylberman V, Ugalde RA, Comerci DJ, Goldbaum FA.

PLoS One. 2010 Feb 25;5(2):e9435. doi: 10.1371/journal.pone.0009435.

32.

Metabolic control of virulence genes in Brucella abortus: HutC coordinates virB expression and the histidine utilization pathway by direct binding to both promoters.

Sieira R, Arocena GM, Bukata L, Comerci DJ, Ugalde RA.

J Bacteriol. 2010 Jan;192(1):217-24. doi: 10.1128/JB.01124-09.

33.

Differential composition of culture supernatants from wild-type Brucella abortus and its isogenic virB mutants.

Delpino MV, Comerci DJ, Wagner MA, Eschenbrenner M, Mujer CV, Ugalde RA, Fossati CA, Baldi PC, Delvecchio VG.

Arch Microbiol. 2009 Jul;191(7):571-81. doi: 10.1007/s00203-009-0484-9. Epub 2009 May 13.

PMID:
19436993
34.

Genomic analysis of Campylobacter fetus subspecies: identification of candidate virulence determinants and diagnostic assay targets.

Moolhuijzen PM, Lew-Tabor AE, Wlodek BM, Agüero FG, Comerci DJ, Ugalde RA, Sanchez DO, Appels R, Bellgard M.

BMC Microbiol. 2009 May 8;9:86. doi: 10.1186/1471-2180-9-86.

35.

Phosphatidylethanolamine synthesis is required for optimal virulence of Brucella abortus.

Bukata L, Altabe S, de Mendoza D, Ugalde RA, Comerci DJ.

J Bacteriol. 2008 Dec;190(24):8197-203. doi: 10.1128/JB.01069-08. Epub 2008 Oct 17.

36.

Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1.

Salcedo SP, Marchesini MI, Lelouard H, Fugier E, Jolly G, Balor S, Muller A, Lapaque N, Demaria O, Alexopoulou L, Comerci DJ, Ugalde RA, Pierre P, Gorvel JP.

PLoS Pathog. 2008 Feb 8;4(2):e21. doi: 10.1371/journal.ppat.0040021.

37.

Blue-light-activated histidine kinases: two-component sensors in bacteria.

Swartz TE, Tseng TS, Frederickson MA, Paris G, Comerci DJ, Rajashekara G, Kim JG, Mudgett MB, Splitter GA, Ugalde RA, Goldbaum FA, Briggs WR, Bogomolni RA.

Science. 2007 Aug 24;317(5841):1090-3.

38.

A bile salt hydrolase of Brucella abortus contributes to the establishment of a successful infection through the oral route in mice.

Delpino MV, Marchesini MI, Estein SM, Comerci DJ, Cassataro J, Fossati CA, Baldi PC.

Infect Immun. 2007 Jan;75(1):299-305. Epub 2006 Nov 6.

39.

A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection.

Spera JM, Ugalde JE, Mucci J, Comerci DJ, Ugalde RA.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16514-9. Epub 2006 Oct 19.

40.

Brucella abortus synthesizes phosphatidylcholine from choline provided by the host.

Comerci DJ, Altabe S, de Mendoza D, Ugalde RA.

J Bacteriol. 2006 Mar;188(5):1929-34.

41.

Whole-genome analyses of speciation events in pathogenic Brucellae.

Chain PS, Comerci DJ, Tolmasky ME, Larimer FW, Malfatti SA, Vergez LM, Aguero F, Land ML, Ugalde RA, Garcia E.

Infect Immun. 2005 Dec;73(12):8353-61.

42.

Integration host factor is involved in transcriptional regulation of the Brucella abortus virB operon.

Sieira R, Comerci DJ, Pietrasanta LI, Ugalde RA.

Mol Microbiol. 2004 Nov;54(3):808-22.

43.

N-terminal-capturing screening system for the isolation of Brucella abortus genes encoding surface exposed and secreted proteins.

Marchesini MI, Ugalde JE, Czibener C, Comerci DJ, Ugalde RA.

Microb Pathog. 2004 Aug;37(2):95-105.

PMID:
15312849
44.

Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine.

Ugalde JE, Comerci DJ, Leguizamón MS, Ugalde RA.

Infect Immun. 2003 Nov;71(11):6264-9.

45.

Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuole.

Comerci DJ, Martínez-Lorenzo MJ, Sieira R, Gorvel JP, Ugalde RA.

Cell Microbiol. 2001 Mar;3(3):159-68.

PMID:
11260139
46.
47.

Vector development for the expression of foreign proteins in the vaccine strain Brucella abortus S19.

Comerci DJ, Pollevick GD, Vigliocco AM, Frasch AC, Ugalde RA.

Infect Immun. 1998 Aug;66(8):3862-6.

Supplemental Content

Loading ...
Support Center